Literature DB >> 17989383

Duration of humoral immunity to common viral and vaccine antigens.

Ian J Amanna1, Nichole E Carlson, Mark K Slifka.   

Abstract

BACKGROUND: Maintenance of long-term antibody responses is critical for protective immunity against many pathogens. However, the duration of humoral immunity and the role played by memory B cells remain poorly defined.
METHODS: We performed a longitudinal analysis of antibody titers specific for viral antigens (vaccinia, measles, mumps, rubella, varicella-zoster virus, and Epstein-Barr virus) and nonreplicating antigens (tetanus and diphtheria) in 45 subjects for a period of up to 26 years. In addition, we measured antigen-specific memory B cells by means of limiting-dilution analysis, and we compared memory B-cell frequencies to their corresponding serum antibody levels.
RESULTS: Antiviral antibody responses were remarkably stable, with half-lives ranging from an estimated 50 years for varicella-zoster virus to more than 200 years for other viruses such as measles and mumps. Antibody responses against tetanus and diphtheria antigens waned more quickly, with estimated half-lives of 11 years and 19 years, respectively. B-cell memory was long-lived, but there was no significant correlation between peripheral memory B-cell numbers and antibody levels for five of the eight antigens tested.
CONCLUSIONS: These studies provide quantitative analysis of serologic memory for multiple antigens in subjects followed longitudinally over the course of more than one decade. In cases in which multiple exposures or repeated vaccinations were common, memory B-cell numbers did not correlate with antibody titers. This finding suggests that peripheral memory B cells and antibody-secreting plasma cells may represent independently regulated cell populations and may play different roles in the maintenance of protective immunity. Copyright 2007 Massachusetts Medical Society.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17989383     DOI: 10.1056/NEJMoa066092

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  500 in total

1.  Antiviral immunity following smallpox virus infection: a case-control study.

Authors:  Erika Hammarlund; Matthew W Lewis; Jon M Hanifin; Motomi Mori; Caroline W Koudelka; Mark K Slifka
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Intrinsic defects in B cell response to seasonal influenza vaccination in elderly humans.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Ana Marie Landin; Mitch Phillips; Suzanne C Lechner; John G Ryan; Bonnie B Blomberg
Journal:  Vaccine       Date:  2010-10-23       Impact factor: 3.641

Review 3.  Vaccination: the present and the future.

Authors:  Saheli Sadanand
Journal:  Yale J Biol Med       Date:  2011-12

4.  Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Mitch Phillips; Nicholas V Mendez; Ana Marie Landin; Bonnie B Blomberg
Journal:  Int Immunol       Date:  2012-01-25       Impact factor: 4.823

Review 5.  No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.

Authors:  Thomas C Mitchell; Carolyn R Casella
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

6.  Human Extrafollicular CD4+ Th Cells Help Memory B Cells Produce Igs.

Authors:  Sang Taek Kim; Jin-Young Choi; Begona Lainez; Vincent P Schulz; David E Karas; Eric D Baum; Jennifer Setlur; Patrick G Gallagher; Joe Craft
Journal:  J Immunol       Date:  2018-07-20       Impact factor: 5.422

7.  Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.

Authors:  Dominic F Kelly; Matthew D Snape; Kirsten P Perrett; Elizabeth A Clutterbuck; Susan Lewis; Geraldine Blanchard Rohner; Meryl Jones; Ly-Mee Yu; Andrew J Pollard
Journal:  Immunology       Date:  2009-05       Impact factor: 7.397

Review 8.  Harnessing CD4⁺ T cell responses in HIV vaccine development.

Authors:  Hendrik Streeck; M Patricia D'Souza; Dan R Littman; Shane Crotty
Journal:  Nat Med       Date:  2013-02-06       Impact factor: 53.440

9.  HLA-DPB1 and anti-HBs titer kinetics in hepatitis B booster recipients who completed primary hepatitis B vaccination during infancy.

Authors:  T-W Wu; C-C Chu; H-W Chang Liao; S-K Lin; T-Y Ho; M Lin; H H Lin; L-Y Wang
Journal:  Genes Immun       Date:  2013-11-28       Impact factor: 2.676

10.  The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals.

Authors:  Peter D Crompton; Marko Mircetic; Greta Weiss; Amy Baughman; Chiung-Yu Huang; David J Topham; John J Treanor; Iñaki Sanz; F Eun-Hyung Lee; Anna P Durbin; Kazutoyo Miura; David L Narum; Ruth D Ellis; Elissa Malkin; Gregory E D Mullen; Louis H Miller; Laura B Martin; Susan K Pierce
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.